(Q38191266)

30 August 2017

1 reference

title

Targeting epigenetic regulators for cancer therapy (English)

1 reference

30 August 2017

3

1 reference

30 August 2017

8

Xiaole Shirley Liu

1 reference

30 August 2017

Susan Wee

1

1 reference

30 August 2017

Dash Dhanak

2

1 reference

30 August 2017

Scott A Armstrong

4

1 reference

30 August 2017

Robert A Copeland

5

1 reference

30 August 2017

Robert Sims

6

1 reference

30 August 2017

Stephen B Baylin

7

1 reference

30 August 2017

Liang Schweizer

9

1 reference

30 August 2017

language of work or name

English

0 references

publication date

1 February 2014

1 reference

Annals of the New York Academy of Sciences

30 August 2017

published in

1 reference

30 August 2017

volume

1309

1 reference

30 August 2017

page(s)

30-36

1 reference

Genetic and epigenetic basis of chronic lymphocytic leukemia

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12356

hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12356

Comparing the DNA hypermethylome with gene mutations in human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12356

Epigenetic changes during disease progression in a murine model of human chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12356

Targeting the epigenome for treatment of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12356

Targeting the epigenome in lung cancer: expanding approaches to epigenetic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12356

Translating the Histone Code

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12356

How chromatin-binding modules interpret histone modifications: lessons from professional pocket pickers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12356

Multivalent engagement of chromatin modifications by linked binding modules

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12356

ATRX ADD domain links an atypical histone methylation recognition mechanism to human mental-retardation syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12356

Targeting epigenetic programs in MLL-rearranged leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12356

MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12356

Polycomb repressive complex 2 is required for MLL-AF9 leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12356

Potent inhibition of DOT1L as treatment of MLL-fusion leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12356

Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12356

Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12356

Chromatin modifications as therapeutic targets in MLL-rearranged leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12356

Targeting genetic alterations in protein methyltransferases for personalized cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12356

EZH2 in normal and malignant hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12356

Targeting MYC dependence in cancer by inhibiting BET bromodomains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12356

BET bromodomain inhibition as a therapeutic strategy to target c-Myc

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12356

A decade of exploring the cancer epigenome - biological and translational implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12356

Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina-associated domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12356

Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12356

Many keys to push: diversifying the 'readership' of plant homeodomain fingers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12356

EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12356

21 January 2018

Identifiers

DOI

10.1111/NYAS.12356

1 reference

30 August 2017

1 reference